| Literature DB >> 32183475 |
Miguel Angel Rodriguez-Calero1,2,3, Joan Ernest de Pedro-Gomez2,3, Luis Javier Molero-Ballester4, Ismael Fernandez-Fernandez4, Catalina Matamalas-Massanet4, Luis Moreno-Mejias4, Ian Blanco-Mavillard2,3,4, Ana Belén Moya-Suarez5,6, Celia Personat-Labrador2, José Miguel Morales-Asencio6.
Abstract
BACKGROUND: Difficult peripheral intravenous cannulation (DPIVC) is associated with serious complications related to vascular access. These complications might be avoided if the risk factors were identified previously, enabling the detection of potentially difficult situations at an early stage. The aim of this study is to consider these risk factors, to determine the influence of the hospital setting, to examine the association between DPIVC and the different techniques of catheter insertion and to analyse the importance of the clinician's experience in this context.Entities:
Keywords: cardiovascular system; hospitalization; peripheral venous catheterization; risk factors
Year: 2020 PMID: 32183475 PMCID: PMC7141318 DOI: 10.3390/jcm9030799
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
General Description of the Sample.
| Variable | TOTAL | DPIVC (Cases) | NO DPIVC (Controls) | |
|---|---|---|---|---|
| AGE | 64.3 (17.6) | 65.8 (19.1) | 64.2 (17.4) | 0.193 |
| GENDER | ||||
| Female | 1338 (50.3%) | 136 (61.5%) | 1202 (49.2%) | <0.001 |
| Male | 1324 (49.7%) | 85 (38.5%) | 1239 (50.8%) | |
| TYPE OF UNIT | ||||
| Medical hospitalization | 1097 (41.2%) | 85 (38.5%) | 1012 (41.5%) | 0.386 |
| Surgical hospitalization | 707 (26.9%) | 65 (29.4%) | 652 (26.7%) | 0.386 |
| A&E / Critical care | 504 (18.9%) | 57 (25.8%) | 447 (18.3%) | 0.007 |
| Surgical area | 164 (6.2%) | 10 (4.5%) | 154 (6.3%) | 0.291 |
| MAS | 180 (6.8%) | 4 (1.8%) | 176 (7.2%) | 0.002 |
| WORK SHIFT | ||||
| 8 a.m.–3 p.m. | 1258 (47.3%) | 101 (45.7%) | 1157 (47.4%) | 0.628 |
| 3 p.m.–10 p.m. | 812 (30.5%) | 83 (37.6%) | 729 (29.9%) | 0.017 |
| 10 p.m.–8 a.m. | 592 (22.2%) | 37 (16.7%) | 555 (22.7%) | 0.040 |
| MAIN DIAGNOSIS / REASON FOR HOSPITAL ADMISSION | ||||
| Diseases of the digestive system (K00-K95) | 522 (19.6%) | 49 (22.2%) | 473 (19.4%) | 0.316 |
| Diseases of the circulatory system (I00-I99) | 333 (12.5%) | 24 (10.9%) | 309 (12.7%) | 0.439 |
| Diseases of the musculoskeletal system and connective tissue (M00-M99) | 328 (12.3%) | 19 (8.6%) | 309 (12.7%) | 0.079 |
| Diseases of the respiratory system (J00-J99) | 325 (12.2%) | 26 (11.8%) | 299 (12.2%) | 0.833 |
| Diseases of the genitourinary system (N00-N99) | 236 (8.9%) | 12 (5.4%) | 224 (9.2%) | 0.061 |
| Neoplasms (C00-D49) | 200 (7.5%) | 12 (5.4%) | 188 (7.7%) | 0.220 |
| Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99) | 130 (4.9%) | 26 (11.8%) | 104 (4.3%) | <0.001 |
| Factors influencing health status and contact with health services (Z00-Z99) | 116 (4.4%) | 4 (1.8%) | 112 (4.6%) | 0.053 |
| Certain infectious and parasitic diseases (A00-B99) | 66 (2.5%) | 5 (2.3%) | 61 (2.5%) | 0.829 |
| Diseases of the skin and subcutaneous tissue (L00-L99) | 60 (2.5%) | 9 (4.1%) | 51 (2.1%) | 0.057 |
| Diseases of the eye and adnexa (H00-H59) | 57(2.1%) | 3 (1.4%) | 54 (2.2%) | 0.401 |
| Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89) | 55 (2.1%) | 4 (1.8%) | 51 (2.1%) | 0.780 |
| Injury, poisoning and certain other consequences of external causes (S00-T88) | 54 (2.0%) | 7 (3.2%) | 47 (1.9%) | 0.210 |
| Diseases of the nervous system (G00-G99) | 48 (1.8%) | 6 (2.7%) | 42 (1.7%) | 0.287 |
| Endocrine, nutritional and metabolic diseases (E00-E89) | 44 (1.7%) | 5 (2.3%) | 39 (1.6%) | 0.458 |
| Unknown / undefined | 41 (1.5%) | 2 (0.9%) | 39 (1.6%) | 0.423 |
| Mental and behavioural disorders (F01-F99) | 22 (0.8%) | 3 (1.4%) | 19 (0.8%) | 0.363 |
| Diseases of the ear and mastoid process (H60-H95) | 18 (0.7%) | 2 (0.9%) | 16 (0.7%) | 0.665 |
| Pregnancy, childbirth and the puerperium (O00-O9A) | 3 (0.1%) | 1 (0.5%) | 2 (0.1%) | 0.116 |
| Congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) | 2 (0.1%) | 1 (0.5%) | 1 (0.0%) | 0.033 |
| External causes of morbidity and mortality (V00-Y99) | 2 (0.1%) | 1 (0.5%) | 1 (0.0%) | 0.033 |
A&E: Accident and Emergency; MAS: Major Ambulatory Surgery.
Bivariate analysis of risk factors.
| Variable | Total | DPIVC | NO DPIVC |
|
|---|---|---|---|---|
| Age >65 years | 1441 (54.1) | 130 (58.8) | 1311 (53.7) | 0.159 |
| Female sex | 1338 (50.3) | 136 (61.5) | 1202 (49.2) | 0.001 |
| Non-palpable veins | 498 (18.) | 110 (49.7) | 388 (15.9) | <0.001 |
| Non-visible veins | 793 (29.8) | 121 (54.7) | 672 (27.5) | <0.001 |
| History of DPIVC | 1108 (41.6) | 185 (83.7) | 923 (37.8) | <0.001 |
| Upper limb alterations | 450 (16.9) | 81 (36.6) | 369 (15.1) | <0.001 |
| Acute | 320 (12.0) | 51 (23.0) | 269 (11.0) | <0.001 |
| Chronic | 176 (6.6) | 33 (14.9) | 143 (5.8) | <0.001 |
| Previous catheters inserted during current hospitalization | 1592 (59.8%) | 147 (66.52) | 1445 (59.2) | 0.044 |
| Admission to hospital / A&E in the last 90 days | 544 (20.4) | 56 (25.3) | 488 (19.9) | 0.068 |
| Diabetes mellitus | 586 (22.0) | 50 (21.9) | 536 (22.6) | 0.866 |
| Parenteral drug abuse | 9 (0.3) | 2 (0.9) | 7 (0.2) | 0.169 |
| Chemotherapy | 145 (5.4) | 12 (5.4) | 133 (5.4) | 0.999 |
| Haemodialysis | 20 (0.8) | 4 (1.8) | 16 (0.7) | 0.078 |
| BMI | ||||
| <18.5 | 241 (9.1) | 28 (13.0) | 213 (9.0) | <0.001 |
| 18.5 - 30 | 1827 (68.6) | 123 (57.2) | 1704 (71.7) | |
| >30 | 523 (19.6) | 64 (29.8) | 459 (19.3) | |
| COPD | 277 (10.4) | 31 (14.03) | 246 (10.8) | 0.084 |
DPIVC: Difficult peripheral intravenous cannulation; BMI: Body Mass Index; COPD: Chronic obstructive pulmonary disease.
Predictive model of DPIVC risk factors.
| Unadjusted | Adjusted | ||||
|---|---|---|---|---|---|
| OR | 95%CI | OR | 95%CI |
| |
| Female sex | 1.65 | (1.24 to 2.19) | 1.10 | (0.76 to 1.6) | 0.600 |
| Non- palpable veins | 5.24 | (3.94 to 6.97) | 2.74 | (1.85 to 4.06) | 0.000* |
| Non- visible veins | 3.19 | (2.41 to 4.21) | 1.28 | (0.86 to 1.89) | 0.221 |
| History of DPIVC | 8.45 | (5.86 to 12.19) | 3.53 | (2.17 to 5.73) | 0.000* |
| Upper limb alterations | 3.25 | (2.42 to 4.36) | 1.24 | (0.51 to 3.01) | 0.634 |
| Acute upper limb alterations | 2.42 | (1.73 to 3.4) | 1.62 | (0.67 to 3.91) | 0.281 |
| Chronic upper limb alterations | 2.82 | (1.88 to 4.24) | 1.31 | (0.57 to 3.02) | 0.526 |
| Previous catheters inserted during current hospitalization | 1.37 | (1.02 to 1.83) | 0.86 | (0.51 to 1.46) | 0.574 |
| BMI >30 | 1.88 | (1.42 to 2.49) | 1.04 | (0.7 to 1.54) | 0.862 |
| Puncture site: Antecubital fossa | - | - | 1.84 | (1.14 to 2.95) | 0.012* |
| Puncture site: Forehand | - | - | 0.66 | (0.41 to 1.04) | 0.075 |
| Unit: Medical ward | - | - | 0.53 | (0.17 to 1.58) | 0.254 |
| Unit: Surgical ward | - | - | 1.10 | (0.37 to 3.23) | 0.861 |
| Unit: A&E / Critical care | - | - | 1.09 | (0.38 to 3.13) | 0.870 |
| Unit: Surgical area / MAS | - | - | 0.54 | (0.13 to 2.17) | 0.385 |
DPIVC: Difficult peripheral intravenous cannulation; BMI: Body Mass Index; A&E: Accident and Emergency; MAS: Major Ambulatory Surgery.
Refined predictive model of DPIVC risk factors.
| Crude Data | Refined | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI | B | OR | 95% CI |
| |
| History of DPIVC | 8.45 | (5.86 to 12.19) | 1.59 | 4.92 | (3.17 to 7.63) | <0.001 |
| Non-palpable veins | 5.24 | (3.94 to 6.97) | 0.86 | 2.35 | (1.65 to 3.36) | <0.001 |
| Acute upper limb alterations | 2.42 | (1.73 to 3.4) | 0.44 | 1.56 | (1.06 to 2.30) | 0.024 |
| Puncture site: antecubital fossa | 3.48 | (2.39 to 5.07) | 0.61 | 1.84 | (1.23 to 2.75) | 0.030 |
| Puncture site: forehand | 0.29 | (0.2 to 0.42) | −0.51 | 0.60 | (0.40 to 0.90) | 0.014 |
Hosmer-Lemeshow: χ2: 6.58; p = 0.254; R2Nagelkerke: 0.20. DPIVC: Difficult peripheral intravenous cannulation.
Characteristics of the patients with DPIVC according to hospitalisation unit.
| Medical | Surgical | A&E | Operating Theatre | MAS |
| |
|---|---|---|---|---|---|---|
| Patients with DPIVC | 85 (7.7%) | 65 (9.1%) | 57 (11.3%) | 10 (6.1%) | 4 (2.2%) | 0.002 |
| Age >65 years | 54 (63.8%) | 38 (58.5%) | 32 (56.1%) | 3 (30.0%) | 3 (75.0%) | 0.307 |
| Female sex | 56 (65.9%) | 38 (58.5%) | 37 (64.9%) | 2 (20.0%) | 3 (75.0%) | 0.067 |
| Non-palpable veins | 44 (51.8%) | 31 (47.7%) | 31 (55.4%) | 3 (33.3%) | 1 (25.0%) | 0.578 |
| Non-visible veins | 44 (51.8%) | 39 (60%) | 32 (58%) | 6 (66.7%) | 0 (0%) | 0.158 |
| History of DPIVC | 75 (88.2%) | 50 (76.9%) | 50 (87.7%) | 8 (80.0%) | 2 (50.0%) | 0.108 |
| Upper limb alterations | 48 (62.3%) | 20 (30.8%) | 10 (21.7%) | 3 (37.5%) | 0 (0%) | <0.001 |
| Acute | 39 (52.0%) | 12 (18.5%) | 9 (19.1%) | 1 (16.7%) | 0 (0%) | <0.001 |
| Chronic | 16 (22.5%) | 8 (12.5%) | 8 (17.4%) | 1 (16.7%) | 0 (0%) | 0.520 |
| Previous catheters inserted during current hospitalization | 73 (85.9%) | 59 (90.8%) | 13 (22.8%) | 1 (10.0%) | 1 (25.0%) | <0.001 |
| Admission to hospital / A&E in the last 90 days | 21 (24.7%) | 12 (18.5%) | 21 (37.5%) | 1 (10.0%) | 1 (25.0%) | 0.124 |
| Diabetes mellitus | 18 (21.2%) | 15 (23.1%) | 14 (24.6%) | 3 (30.0%) | 0 (0%) | 0.789 |
| Parenteral drug abuse | 0 (0%) | 1 (1.5%) | 1 (1.8%) | 0 (0%) | 0 (0%) | 0.799 |
| Chemotherapy | 4 (4.7%) | 4 (6.2%) | 4 (7.0%) | 0 (0%) | 0 (0%) | 0.872 |
| Haemodialysis | 0 (0%) | 2 (3.1%) | 2 (3.5%) | 0 (0%) | 0 (0%) | 0.508 |
| BMI | 0.438 | |||||
| <18.5 | 15 (18.3%) | 6 (9.2%) | 6 (10.9%) | 1 (11.1%) | 0 (0%) | |
| 18.5 - 30 | 43 (52.4%) | 42 (64.6%) | 29 (52.7%) | 5 (55.6%) | 4 (100%) | |
| >30 | 24 (29.3%) | 17 (26.2%) | 20 (36.4%) | 3 (33.3%) | 0 (0%) | |
| COPD | 12 (14.1%) | 13 (20.0%) | 4 (7.0%) | 2 (20.0%) | 0 (0%) | 0.268 |
DPIVC: Difficult peripheral intravenous cannulation; BMI: Body Mass Index; COPD: Chronic obstructive pulmonary disease; A&E: Accident and Emergency; MAS: Major Ambulatory Surgery.
Cannulation technique according to difficulty.
| Variable | Total | DPIVC | NO DPIVC |
|
|---|---|---|---|---|
| SBP before cannulation | 126.8 (20.4) | 125.4 (21.7) | 128.0 (21.2) | 0.075 |
| DBP before cannulation | 70.6 (12.3) | 69.6 (12.9) | 71.4 (12.9) | 0.151 |
| Number of punctures | 1.3 (0.7) | 3.3 (1.1) | 1.15 (0.3) | <0.001 |
| First attempt success | 2087 (78.39%) | 2074 (85.00%) | 13 (5.90%) | |
| Calibre of catheter inserted | ||||
| 14 gauge | 1 (0.1%) | 0 (0%) | 1 (0.1%) | <0.001 |
| 16 gauge | 6 (0.2%) | 0 (0%) | 6 (0.2%) | |
| 18 gauge | 659 (24.9%) | 26 (12.3%) | 633 (25.9%) | |
| 20 gauge | 1506 (56.8%) | 96 (45.5%) | 1410 (57.8%) | |
| 22 gauge | 428 (16.1%) | 71 (33.6%) | 357 (14.6%) | |
| 24 gauge | 43 (1.6%) | 10 (4.7%) | 33 (1.4%) | |
| CANNULATION SITE | ||||
| Forehand | 1216 (45.7%) | 52 (23.5%) | 1164 (47.7%) | <0.001 |
| Hand | 841 (31.6%) | 69 (31.2%) | 772 (31.6%) | |
| Antecubital fossa | 513 (19.3%) | 69 (31.2%) | 444 (18.2%) | |
| Not recorded | 92 (3.5%) | 31 (14.0%) | 61 (2.5%) | |
| Registered nurses participating (n) | 1.3 (0.7) | 1.6 (0.7) | 1.1 (0.3) | <0.001 |
| Nursing assistants participating (n) | 0.1 (0.3) | 0.4 (0.5) | 0.2 (0.4) | <0.001 |
| Time to cannulation (minutes) | 8.8 (7.1) | 24.0 (13.5) | 7.6 (5.3) | <0.001 |
| Pain intensity (Visual Analogue Scale) | 1.8 (1.9) | 3.0 (2.6) | 1.8 (1.9) | <0.001 |
DPIVC: Difficult peripheral intravenous cannulation; SBP: Systolic blood pressure; DBP: Diastolic blood pressure.
Variables related to the nurses performing the cannulation.
| Variable | Total | DPIVC | NO DPIVC |
|
|---|---|---|---|---|
| Age | 39.6 (6.9) | 39.1 (7.1) | 39.1 (6.2) | 0.893 |
| Sex | ||||
| Female | 2086 (83.1%) | 155 (78.7%) | 1931 (83.5%) | 0.082 |
| Male | 423 (16.9%) | 42 (21.3%) | 381 (16.5%) | |
| Nursing experience (years) | 16.3 (6.4) | 15.6 (7.0) | 15.6 (6.7) | 0.758 |
| PIVC experience (years) | 14.5 (6.5) | 13.6 (7.1) | 13.8 (6.6) | 0.838 |
DPIVC: Difficult peripheral intravenous cannulation.